(Q28295707)

1

0 references

E C Matheson

2

0 references

A G Hall

3

0 references

L A Hogarth

Nucleosides, Nucleotides & Nucleic Acids

4

0 references

language of work or name

English

0 references

publication date

October 2004

0 references

published in

0 references

volume

23

0 references

issue

8-9

0 references

page(s)

1385-91

0 references

cites work

Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism

1 reference

https://api.crossref.org/works/10.1081/NCN-200027637

Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/NCN-200027637

Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/NCN-200027637

Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties

21 April 2017

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

The use of denaturing high-pressure liquid chromatography for the detection of mutations in thiopurine methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637

Topoisomerase II inhibitor-related acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FNCN-200027637